Milner Therapeutics to establish new genomics laboratory for drug discovery
The new state-of-the-art facility is set to be operational in early 2024
Read More
Tag: Milner Therapeutics Institute
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
